FOS and breast neoplasm: First, Fra-1 and c-Fos overexpression in breast tumor tissues in comparison with undetectable levels in normal tissue confers per se high tumorigenic tissue specificity because the deletion mutants will interfere only with the activity of these proteins in cells overexpressing their full-length versions.